SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Anke Van der Perren, Jaan Toelen, Cindy Casteels, Francesca Macchi, Anne-Sophie Van Rompuy, Sophie Sarre, Nicolas Casadei, Silke Nuber, Uwe Himmelreich, Maria Isabel Osorio Garcia, Yvette Michotte, Rudi D'Hooge, Guy Bormans, Koen Van Laere, Rik Gijsbers, Chris Van den Haute, Zeger Debyser, Veerle Baekelandt, Longitudinal follow-up and characterization of a robust rat model for Parkinson's disease based on overexpression of alpha-synuclein with adeno-associated viral vectors, Neurobiology of Aging, 2015, 36, 3, 1543

    CrossRef

  2. 2
    Yu-Ting Sui, Kristin M. Bullock, Michelle A. Erickson, Jing Zhang, W.A. Banks, Alpha synuclein is transported into and out of the brain by the blood–brain barrier, Peptides, 2014, 62, 197

    CrossRef

  3. 3
    Maria Eugenia Herva, Maria Grazia Spillantini, Parkinson's disease as a member of Prion-like disorders, Virus Research, 2014,

    CrossRef

  4. 4
    Javier Blesa, Serge Przedborski, Parkinson’s disease: animal models and dopaminergic cell vulnerability, Frontiers in Neuroanatomy, 2014, 8,

    CrossRef

  5. 5
    Erwan Bezard, Zhenyu Yue, Deniz Kirik, Maria Grazia Spillantini, Animal models of Parkinson's disease: Limits and relevance to neuroprotection studies, Movement Disorders, 2013, 28, 1
  6. 6
    Clévio Nóbrega, Isabel Nascimento-Ferreira, Isabel Onofre, David Albuquerque, Mariana Conceição, Nicole Déglon, Luís Pereira de Almeida, Overexpression of Mutant Ataxin-3 in Mouse Cerebellum Induces Ataxia and Cerebellar Neuropathology, The Cerebellum, 2013, 12, 4, 441

    CrossRef

  7. 7
    Angélique Deleersnijder, Melanie Gerard, Zeger Debyser, Veerle Baekelandt, The remarkable conformational plasticity of alpha-synuclein: blessing or curse?, Trends in Molecular Medicine, 2013, 19, 6, 368

    CrossRef

  8. 8
    Grit Taschenberger, Manuel Garrido, Yuliya Tereshchenko, Mathias Bähr, Markus Zweckstetter, Sebastian Kügler, Aggregation of αSynuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons, Acta Neuropathologica, 2012, 123, 5, 671

    CrossRef

  9. 9
    Hanna S. Lindgren, Mariah J. Lelos, Stephen B. Dunnett, Do alpha-synuclein vector injections provide a better model of Parkinson's disease than the classic 6-hydroxydopamine model?, Experimental Neurology, 2012, 237, 1, 36

    CrossRef

  10. 10
    Karin Löw, Patrick Aebischer, Use of viral vectors to create animal models for Parkinson's disease, Neurobiology of Disease, 2012, 48, 2, 189

    CrossRef

  11. 11
    A Van der Perren, J Toelen, M Carlon, C Van den Haute, F Coun, B Heeman, V Reumers, L H Vandenberghe, J M Wilson, Z Debyser, V Baekelandt, Efficient and stable transduction of dopaminergic neurons in rat substantia nigra by rAAV 2/1, 2/2, 2/5, 2/6.2, 2/7, 2/8 and 2/9, Gene Therapy, 2011, 18, 5, 517

    CrossRef

  12. 12
    Joshua M. Shulman, Philip L. De Jager, Mel B. Feany, Parkinson's Disease: Genetics and Pathogenesis, Annual Review of Pathology: Mechanisms of Disease, 2011, 6, 1, 193

    CrossRef

  13. 13
    Varduhi H. Knaryan, Supriti Samantaray, Charlene Le Gal, Swapan K. Ray, Naren L. Banik, Tracking extranigral degeneration in animal models of Parkinson’s disease: quest for effective therapeutic strategies, Journal of Neurochemistry, 2011, 118, 3
  14. 14
    Birgitte R. Kornum, Simon R.W. Stott, Bengt Mattsson, Liselijn Wisman, Anders Ettrup, Stephan Hermening, Gitte M. Knudsen, Deniz Kirik, Adeno-associated viral vector serotypes 1 and 5 targeted to the neonatal rat and pig striatum induce widespread transgene expression in the forebrain, Experimental Neurology, 2010, 222, 1, 70

    CrossRef

  15. 15
    Jean-Marc Taymans, Mark R. Cookson, Mechanisms in dominant parkinsonism: The toxic triangle of LRRK2, α-synuclein, and tau, BioEssays, 2010, 32, 3
  16. 16
    Nadja Van Camp, Ruth Vreys, Koen Van Laere, Erwin Lauwers, Dirk Beque, Marleen Verhoye, Cindy Casteels, Alfons Verbruggen, Zeger Debyser, Luc Mortelmans, Jan Sijbers, Johan Nuyts, Veerle Baekelandt, Annemie Van der Linden, Morphologic and functional changes in the unilateral 6-hydroxydopamine lesion rat model for Parkinson’s disease discerned with μSPECT and quantitative MRI, Magnetic Resonance Materials in Physics, Biology and Medicine, 2010, 23, 2, 65

    CrossRef

  17. 17
    Toru Yasuda, Hideki Mochizuki, The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson’s disease, Apoptosis, 2010, 15, 11, 1312

    CrossRef

  18. 18
    Ayse Ulusoy, Mickael Decressac, Deniz Kirik, Anders Björklund, Recent Advances in Parkinson’S Disease - Translational and Clinical Research, 2010,

    CrossRef

  19. 19
    Antje Krenz, Björn H. Falkenburger, Ellen Gerhardt, Anja Drinkut, Jörg B. Schulz, Aggregate formation and toxicity by wild-type and R621C synphilin-1 in the nigrostriatal system of mice using adenoviral vectors, Journal of Neurochemistry, 2009, 108, 1
  20. 20
    Nadja Van Camp, Ines Blockx, Marleen Verhoye, Cindy Casteels, Frea Coun, Alexander Leemans, Jan Sijbers, Veerle Baekelandt, Koen Van Laere, Annemie Van der Linden, Diffusion tensor imaging in a rat model of Parkinson's disease after lesioning of the nigrostriatal tract, NMR in Biomedicine, 2009, 22, 7
  21. 21
    Abdelilah Ibrahimi, Greetje Vande Velde, Veerle Reumers, Jaan Toelen, Irina Thiry, Caroline Vandeputte, Sofie Vets, Christophe Deroose, Guy Bormans, Veerle Baekelandt, Zeger Debyser, Rik Gijsbers, Highly Efficient Multicistronic Lentiviral Vectors with Peptide 2A Sequences, Human Gene Therapy, 2009, 20, 8, 845

    CrossRef

  22. 22
    Melanie Gerard, Zeger Debyser, Linda Desender, Johan Baert, Inger Brandt, Veerle Baekelandt, Yves Engelborghs, FK506 binding protein 12 differentially accelerates fibril formation of wild type alpha-synuclein and its clinical mutants A30P or A53T, Journal of Neurochemistry, 2008, 106, 1
  23. 23
    Peter Jenner, Functional models of Parkinson's disease: A valuable tool in the development of novel therapies, Annals of Neurology, 2008, 64, S2
  24. 24
    Marie-Francoise Chesselet, In vivo alpha-synuclein overexpression in rodents: A useful model of Parkinson's disease?, Experimental Neurology, 2008, 209, 1, 22

    CrossRef

  25. 25
    Ayse Ulusoy, Tomas Bjorklund, Stephan Hermening, Deniz Kirik, In vivo gene delivery for development of mammalian models for Parkinson's disease, Experimental Neurology, 2008, 209, 1, 89

    CrossRef

  26. You have free access to this content26
    J. Alegre-Abarrategui, O. Ansorge, M. Esiri, R. Wade-Martins, LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinson's disease, Neuropathology and Applied Neurobiology, 2008, 34, 3
  27. 27
    Inger Brandt, Melanie Gérard, Kjell Sergeant, Bart Devreese, Veerle Baekelandt, Koen Augustyns, Simon Scharpé, Yves Engelborghs, Anne-Marie Lambeir, Prolyl oligopeptidase stimulates the aggregation of α-synuclein, Peptides, 2008, 29, 9, 1472

    CrossRef

  28. 28
    S. Alves, E. Regulier, I. Nascimento-Ferreira, R. Hassig, N. Dufour, A. Koeppen, A. L. Carvalho, S. Simoes, M. C. P. de Lima, E. Brouillet, V. C. Gould, N. Deglon, L. P. de Almeida, Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease, Human Molecular Genetics, 2008, 17, 14, 2071

    CrossRef

  29. 29
    Bernard L. Schneider, Meret N. Gaugler, Patrick Aebischer, Parkinson's Disease, 2008,

    CrossRef

  30. 30
    Martine Geraerts, Olga Krylyshkina, Zeger Debyser, Veerle Baekelandt, Concise Review: Therapeutic Strategies for Parkinson Disease Based on the Modulation of Adult Neurogenesis, STEM CELLS, 2007, 25, 2
  31. 31
    Jessie L. St Martin, Jochen Klucken, Tiago F. Outeiro, Paul Nguyen, Christine Keller-McGandy, Ippolita Cantuti-Castelvetri, Tom N. Grammatopoulos, David G. Standaert, Bradley T. Hyman, Pamela J. McLean, Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra, Journal of Neurochemistry, 2007, 100, 6
  32. 32
    T. Yasuda, S. Miyachi, R. Kitagawa, K. Wada, T. Nihira, Y.-R. Ren, Y. Hirai, N. Ageyama, K. Terao, T. Shimada, M. Takada, Y. Mizuno, H. Mochizuki, Neuronal specificity of α-synuclein toxicity and effect of Parkin co-expression in primates, Neuroscience, 2007, 144, 2, 743

    CrossRef

  33. 33
    Erwin Lauwers, Dirk Bequé, Koen Van Laere, Johan Nuyts, Guy Bormans, Luc Mortelmans, Cindy Casteels, Linda Vercammen, Olivier Bockstael, Bart Nuttin, Zeger Debyser, Veerle Baekelandt, Non-invasive imaging of neuropathology in a rat model of α-synuclein overexpression, Neurobiology of Aging, 2007, 28, 2, 248

    CrossRef

  34. 34
    Ranjita Betarbet, J. Timothy Greenamyre, Parkinson's Disease and Related Disorders, Part I, 2007,

    CrossRef

  35. 35
    Sean M. Kearns, Bjorn Scheffler, A. Katrin Goetz, Dean D. Lin, Harriet D. Baker, Steven N. Roper, Ronald J. Mandel, Dennis A. Steindler, A method for a more complete in vitro Parkinson's model: Slice culture bioassay for modeling maintenance and repair of the nigrostriatal circuit, Journal of Neuroscience Methods, 2006, 157, 1, 1

    CrossRef

  36. 36
    Ranjita Betarbet, Rosa M. Canet-Aviles, Todd B. Sherer, Pier G. Mastroberardino, Chris McLendon, Jin-Ho Kim, Serena Lund, Hye-Mee Na, Georgia Taylor, Neil F. Bence, Ron Kopito, Byoung Boo Seo, Takao Yagi, Akemi Yagi, Gary Klinefelter, Mark R. Cookson, J. Timothy Greenamyre, Intersecting pathways to neurodegeneration in Parkinson's disease: Effects of the pesticide rotenone on DJ-1, α-synuclein, and the ubiquitin–proteasome system, Neurobiology of Disease, 2006, 22, 2, 404

    CrossRef

  37. 37
    Liang-Fong Wong, Lucy Goodhead, Christine Prat, Kyriacos A. Mitrophanous, Susan M. Kingsman, Nicholas D. Mazarakis, Lentivirus-Mediated Gene Transfer to the Central Nervous System: Therapeutic and Research Applications, Human Gene Therapy, 2006, 17, 1, 1

    CrossRef

  38. 38
    Heather L. Melrose, Sarah J. Lincoln, Glenn M. Tyndall, Matthew J. Farrer, Parkinson’s disease: a rethink of rodent models, Experimental Brain Research, 2006, 173, 2, 196

    CrossRef

  39. 39
    Mohan K. Sapru, Jonathan W. Yates, Shea Hogan, Lixin Jiang, Jeremy Halter, Martha C. Bohn, Silencing of human α-synuclein in vitro and in rat brain using lentiviral-mediated RNAi, Experimental Neurology, 2006, 198, 2, 382

    CrossRef

  40. 40
    E Torres, C Monville, S Dunnett, Gene Therapy for Neurological Disorders, 2006,

    CrossRef

  41. 41
    Liang-Fong Wong, Lucy Goodhead, Christine Prat, Kyriacos A. Mitrophanous, Susan M. Kingsman, Nicholas D. Mazarakis, Lentivirus-Mediated Gene Transfer to the Central Nervous System: Therapeutic and Research Applications, Human Gene Therapy, 2005, 0, 0, 051215125756003

    CrossRef

  42. 42
    D. McFarlane, N. Dybdal, M. T. Donaldson, L. Miller, A. E. Cribb, Nitration and Increased α-Synuclein Expression Associated With Dopaminergic Neurodegeneration In Equine Pituitary Pars Intermedia Dysfunction, Journal of Neuroendocrinology, 2005, 17, 2
  43. 43
    Gregor K Wenning, Kurt A Jellinger, The role of α-synuclein and tau in neurodegenerative movement disorders, Current Opinion in Neurology, 2005, 18, 4, 357

    CrossRef

  44. 44
    Martine Geraerts, Martine Michiels, Veerle Baekelandt, Zeger Debyser, Rik Gijsbers, Upscaling of lentiviral vector production by tangential flow filtration, The Journal of Gene Medicine, 2005, 7, 10
  45. 45
    N. Déglon, P. Hantraye, Viral vectors as tools to model and treat neurodegenerative disorders, The Journal of Gene Medicine, 2005, 7, 5
  46. 46
    C. Lo Bianco, B. L. Schneider, M. Bauer, A. Sajadi, A. Brice, T. Iwatsubo, P. Aebischer, Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an  -synuclein rat model of Parkinson's disease, Proceedings of the National Academy of Sciences, 2004, 101, 50, 17510

    CrossRef

  47. 47
    Erin Yoshida, Trevor G. Atkinson, Balu Chakravarthy, Neuroprotective gene expression profiles in ischemic cortical cultures preconditioned with IGF-1 or bFGF, Molecular Brain Research, 2004, 131, 1-2, 33

    CrossRef

  48. 48
    Chris Van den Haute, Kristel Eggermont, Bart Nuttin, Zeger Debyser, Veerle Baekelandt, Lentiviral Vector-Mediated Delivery of Short Hairpin RNA Results in Persistent Knockdown of Gene Expression in Mouse Brain, Human Gene Therapy, 2003, 14, 18, 1799

    CrossRef

  49. 49
    Wojciech Bobela, Lu Zheng, Bernard L. Schneider, Overview of Mouse Models of Parkinson's Disease, Current Protocols in Mouse Biology,
  50. 50
    Naruhiko Sahara, Heather Melrose, Simon D'alton, Jada Lewis, Transgenic Animal Models of Proteinopathies,